Item 9 Labs Corp.
Healthcare · Dental Equipment & Supplies · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY15 | |
|---|---|---|---|---|---|---|
| Revenue | $21.8M | $21.9M | $8.1M | $4.9M | $1.4M | $113,022 |
| Operating income | −$23.1M | −$5.6M | −$5.4M | −$10.1M | −$653,818 | −$4.7M |
| Net income | −$31.2M | −$10.9M | −$12.3M | −$9.9M | −$688,721 | −$4.7M |
| Total assets | $110.8M | $116.8M | $20.7M | $14.5M | $5.0M | $112,665 |
| Total liabilities | $48.8M | $30.7M | $12.6M | $7.1M | $2.5M | $5.1M |
| Equity | $62.0M | $86.1M | $8.0M | $7.3M | $2.6M | −$5.0M |
| EPS (diluted) | $-0.33 | $-0.14 | — | — | — | — |
| Shares out. | 94.9M | 62.7M | 63.7M | 63.6M | 54.8M | 72.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −106.0%
- Net margin
- −143.3%
- Return on equity
- −50.3%
- Return on assets
- −28.1%
- Return on capital (ROCE)
- −32.9%
- Liabilities / assets
- 44.1%
- Debt / equity
- 0.79×
- Book value / share
- $0.65
- Revenue growth (YoY)
- −0.8%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -4.17distress
- Accruals / assets
- −26.1%clean
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 14, 2023
- NT 10-Qmissed a reporting deadline ↗May 15, 2023
- NT 10-Kmissed a reporting deadline ↗Dec 29, 2022
- NT 10-Kmissed a reporting deadline ↗Dec 30, 2021
- NT 10-Kmissed a reporting deadline ↗Dec 29, 2020
- NT 10-Qmissed a reporting deadline ↗Feb 18, 2020
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivership · Director / officer changeJul 20, 2023
- Director / officer changeJul 7, 2023
- Director / officer changeJun 27, 2023
- Terminated a material agreementJun 6, 2023
- Director / officer change · Other material eventMay 22, 2023
- Director / officer changeMay 12, 2023
- Entered a material agreement · New financial obligation · Unregistered equity saleMay 5, 2023
- Debt acceleration / triggering eventApr 5, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13GSCHEDULE 13GFeb 21, 2024
- 10-QFORM 10-QAug 21, 2023
- NT 10-QFORM 12B-25Aug 14, 2023
- 8-KFORM 8-KJul 20, 2023
- 8-KFORM 8-KJul 7, 2023
- 8-KFORM 8-KJun 27, 2023
- 8-KFORM 8-KJun 6, 2023
- 10-QFORM 10-QMay 22, 2023
- 8-KFORM 8-KMay 22, 2023
- NT 10-QFORM 12B-25May 15, 2023
- 8-KFORM 8-KMay 12, 2023
- 8-KFORM 8-KMay 5, 2023
- 8-KFORM 8-KApr 5, 2023
- 8-KFORM 8-KMar 10, 2023
- 10-QFORM 10-QFeb 14, 2023
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.